Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: A joint position statement of the American diabetes association and the European association for the study of diabetes

Diabetes Care

Volumn 40, Issue 1, 2017, Pages 155-157

  Heller, Simon R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; MEGLITINIDE; SULFONYLUREA;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; SELF MONITORING;

EID: 85008187823     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-2215     Document Type: Article

References (24)

1. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988;37: 901-907
2. Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 1988;318:1487-1492
3. Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 1991;40: 223-226
4. Dagogo-Jack SE, Craft S, CryerPE. Hypoglycemiaassociated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 1993;91: 819-828
5. Cryer PE. Mechanisms of hypoglycemiaassociated autonomic failure in diabetes. N Engl J Med 2013;369:362-372
6. Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005;28:1245-1249
7. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: A report of a workgroup of the American Diabetes Association and The Endocrine Society. Diabetes Care 2013;36:1384-1395
8. Cryer PE. The prevention and correction of hypoglycemia. In Handbook of Physiology, Section 7, Volume II, The Endocrine Pancreas and Regulation of Metabolism. Jefferson LS, Cherrington AD, Eds. New York, Oxford University Press, 2001, p. 1057-1092
9. Cryer PE. Hypoglycemia in Diabetes. 3rd ed. Alexandria, VA, American Diabetes Association, 2016, p. 33
10. Frier BM, Heller SR, McCrimmon RJ, Eds. Hypoglycaemia in Clinical Diabetes. 3rd ed. Chichester, U.K., JohnWiley & Sons, 2014, p. 49
11. Heller SR, Macdonald IA. The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness. Diabet Med 1996;13:607-615
12. Choudhary P, Lonnen K, Emery CJ, et al. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin-and sulphonylurea-treated type 2 diabetes. Diabet Med 2009;26:665-672
13. Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997;20:135-141
14. Gonder-Frederick LA, Zrebiec JF, Bauchowitz AU, et al. Cognitive function is disrupted by both hypo-and hyperglycemia in school-aged children with type 1 diabetes: A field study. Diabetes Care 2009;32:1001-1006
15. Fanelli CG, Epifano L, Rambotti AM, et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993;42:1683-1689
16. Fanelli C, Pampanelli S, Epifano L, et al. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 1994;37:1265-1276
17. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hypoglycemia awareness in patients with long-duration insulindependent diabetes. Lancet 1994;344:283:287
18. Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994;43:1426-1434
19. Chow E, Bernjak A, Williams S, et al. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes 2014;63:1738-1747
20. Pistrosch F, Ganz X, Bornstein SR, Birkenfeld AL, Henkel E, HanefeldM. Risk of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: A cohort study under real-world conditions. Acta Diabetol 2015;52:889-895
21. Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010;340:b4909
22. ORIGIN Trial Investigators,Mellbin LG, Rydén L, Riddle MC, et al. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J 2013;34:3137-3144
23. Finfer S, Liu B, Chittock DR, et al.; NICESUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl JMed 2012;367:1108-1118
24. International Hypoglycaemia Study Group. Minimizing hypoglycemia in diabetes. Diabetes Care 2015;38:1583-1591